The biotechnology sector continues robust capital inflows and ecosystem expansion. Patient Square Capital secured $3.1 billion in interim closing for its healthcare investment fund (a86b3ec625ae859c). Plexium raised $60 million to propel its protein degrader pipeline despite setbacks (c3c6aa0104cfd68d). Flagship Pioneering partners with IQVIA to enhance clinical trial capabilities using AI (b1e52d944cacae8b). Emerging hubs like South Carolina are fostering biotech growth through venture funds and local initiatives (8f04f3080508837c). These developments underscore the industry’s sustained momentum amid evolving scientific frontiers.